Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for RPHCF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RPHCF and 80,000+ other tickers.
See exactly how RPHCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RPHCF and 80,000+ other tickers.
Rohto Pharmaceutical Co.,Ltd. operates as a global enterprise, specializing in the manufacturing and distribution of pharmaceuticals, cosmetics, and health-enhancing functional foods. Their extensive product line encompasses a variety of eye care solutions, including eye drops, contact lens maintenance products, and eye washes. They also offer a comprehensive range of facial care items such as cleansers, lotions, and creams. Beyond these, Rohto's offerings extend to topical skin treatments, internal medications (comprising digestive and herbal remedies), and oral health products like…
No recent news available.